February 29, 2024
admin
GPT Healthcare IPO analysis @ Chanakyanipothi.com , India`s Oldest & most Trusted Investment Blog.Operational since 8th December 1999, We are the Only Investment Platform in India, which has successfully completed 21 Years
GPT Healthcare IPO Post listing Review
On 29th February, the scrip is listed at Rs.215, compared to the Issue-price of Rs.186, at a premium of 15.59 %. The listing has been above the expectations of the grey market players. Subsequent to the listing the share is moving around Rs. 204.
GPT Healthcare Grey Market News Today #
Premium: Rs.17,
Small Subject to Rs.1100
big Subject to Rs. 15400
GPT Healthcare Subscription Status
On 26 February 2024 5.00 pm (Day 3) (Closed)
Review: IPO has sailed through with support of QIBs
QIB: 5646664 Shares 17.30 T
NII(10L+): 2823333 Shares 11.98 T
NII (<10L) 1411666 Shares 9.09 T
NII (Total) 4234999 Shares 11.02 T
RII: 9881664 Shares 2.44 T
Total: 19763327 Shares 8.52 T
Total Bids of just Rs.3131.95 Cr
GPT Healthcare Company Details
GPT Healthcare is one of the leading regional corporate healthcare companies in Eastern India . It operates a chain of mid-sized multispecialty hospitals in Eastern India under the “ILS Hospitals” brand and provide integrated healthcare services, with a focus on secondary and tertiary care. As of September 30, 2021, it operates 4 multispecialty hospitals, with a total capacity of 556 beds. It offers a comprehensive range of healthcare services across over 35 specialties and superspecialties. Each of its hospitals also provides integrated diagnostic services and pharmacies that cater to its patients. It strategically focus on the relatively underpenetrated healthcare market in Eastern India
Dr. Om Tantia, the Managing Director and one of its Promoters, is the founder of ILS Hospitals and is an established name in the field of laparoscopic surgery. He has more than 40 years of experience in minimal access surgery and established ILS Hospitals in the year 2000 with the vision of providing quality healthcare services in Eastern India. Its second hospital was set up in Agartala, Tripura in the year 2011 as a multi-specialty tertiary care centre and has a capacity of 205 beds as of September 30, 2021, with 52 beds across various ICUs. Its hospital in Dum Dum, Kolkata (West Bengal), established in the year 2013, has 150 beds, including 51 beds across various ICUs and HDUs as of September 30, 2021, and is authorized to perform renal transplants. The hospital in Howrah (West Bengal) is a greenfield tertiary care hospital commissioned in the year 2019, with 116 beds as of September 30, 2021, including 43 beds across ICUs.
It endeavors to provide quality and affordable healthcare services to all its patients, with 1,767 employees ,75 full-time consultants and 314 visiting consultants as of September 30, 2021. It wholly owns and manages each of its hospitals through a separate professional management team.
The healthcare delivery market in India is expected to grow at a CAGR of 15% – 17% between Fiscal Years 2021 and 2025 and reach Rs 7.67 trillion in Fiscal Year 2025. Eastern India has a population of approximately 230 million people, contributing to 17.1% of India’s population as
The Company does not depend on occupancy from government schemes or corporate tie-ups. Its revenue from private patients comprised 87.90% of its revenue from operations in Fiscal Year 2021.
It also benefits from medical value travel stemming from neighboring countries such as Bangladesh, Nepal and Bhutan, from patients who prefer to obtain quality healthcare services in Eastern India.
For more information, click www.ilshospitals.com
The Promoters of GPT Healthcare
GPT sons Pvt ltd , Dwarika Prasad Tantia ,
Dr Om Tantia & Shree Gopal Tantia
GPT Healthcare IPO Main Objects
The Offer comprises of the Fresh Issue and Offer for Sale.
The Company proposes to utilise the Net Proceeds towards Purchase of medical equipments.
GPT Healthcare IPO Details
IPO opens on 22 February , 2024
IPO closes on 26 February ,2024
Issue Type: Book Built Issue IPO
Issue : up to 28233323 Shares /Rs 525.14 Crore
* Fresh Issue of 2150537 Sh/ Rs.40.00 Cr
* Offer for Sale Up to 26082786 Sh/ Rs. 485.14 Cr
Face Value per share : Rs. 10
GPT Healthcare IPO Price Band Per Equity Share: Rs. 177-186
GPT Healthcare IPO Retail Lot Size 80 Shares
GPT Healthcare Listing will at BSE,NSE
Shares offered to
QIB (50%) 14116662 Shares = Rs 262.57 Cr
NII (15%) 42344999 Shares = Rs 78.88 Crs
RII (35%) 9881663 Shares = Rs 183.80 Crs
Lot size: 80 Shares = 123521 Forms
Min Retail: 80 Sh , Rs. 14880
Max Retail: 1040 Sh, Rs 193440
S HNI Min: 1120 Sh, Rs. 208320
S HNI Max: 5360 Sh, Rs. 996960
B HNI Min 5440 Sh, Rs. 1011840
GPT Healthcare IPO Tentative timeTable
GPT Healthcare IPO Allotment on 27 February 2024
Unblocking of ASBA 28 February 2024
Credit to Demat Accounts 28 February 2024
Listing on 29 February 2024
GPT Healthcare IPO Financial & Analytical Ratios
Earnings per Share 2020-21 Rs 2.64
Earnings per Share 2021-22 Rs 5.21
Earnings per Share 2022-23 Rs 4.88
Book Value of the Share as on 31.3.2023 Rs 20.54
Return on Net Worth: 20-21 15.90 %
Return on Net Worth: 21-22: 26.54 %
Return on Net Worth: 22-23 23.77 %
Ratio Analysis
Upper Price Band/last EPS: 38.11
Upper offer price/Book Value Ratio 9.05
GPT Healthcare IPO Peer Comparison:
Global Health @ PE Multiple of 90.29
Krishna Institute @ PE Multiple of 49.51
Jupiter Lifeline @ PE Multiple of 81.73
Yatharth Hospitals @ PE Multiple of 37.66
Kovai Medical @ PE Multiple of 29.93
Shalby Ltd @ PE Multiple of 49.01
GPT Healthcare IPO Lead Managers
DAM Capital Advisors ,SBI Capital Markets
Registrar to GPT Healthcare IPO
Linkintime India pvt ltd.
Registered Office of GPT Healthcare
GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700106
Company Secretary & Compliance Officer : Ankur Sharma
IPO Guidace
GPT Healthcare is one of the leading regional corporate healthcare companies in Eastern India . It operates a chain of mid-sized multispecialty hospitals in Eastern India under the “ILS Hospitals” brand and provide integrated healthcare services, with a focus on secondary and tertiary care. As of September 30, 2021, it operates 4 multispecialty hospitals, with a total capacity of 556 beds. It offers a comprehensive range of healthcare services across over 35 specialties and super specialties.
The healthcare delivery market in India is expected to grow at a CAGR of 15% – 17% between Fiscal Years 2021 and 2025.
Just have a look at the ratio analysis. Upper Price Band/last EPS: 38.11 & Upper offer price/Book Value Ratio 9.05.
The shares are offered at the PE Multiple of 38.11. If we consider the valuations of listed peer healthcare companies, this IPO offers limited room for listing gains. IPO size is just Rs. 525.14 Cr. So oversubscription will not be an issue. Not so attractive.
#This is only coverage of News related to Grey Market . We donot deal in Grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
